This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Bernhard F. Manger, MD; Roswitha Stix, MD; Anna Luisa Beck, CTA; Joachim R. Kalden, MD, PhD
Department of Clinical Immunology and Rheumatology University Erlangen-Nuremberg Krankenhausstrasse 12 D-8520 Erlangen, Germany

Arch Dermatol. 1983;119(10):792.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

A letter to the editor in the December 1978 issue of The Lancet initiated a discussion of the usefulness of cimetidine therapy in patients with psoriasis or psoriatic arthritis.¹ Regarding the efficacy of this therapeutic approach, a number of rather contradictory results were published, describing both beneficial and neutral effects on skin and/or joint lesions.^2-5 Our observation of a single patient with psoriatic arthritis in whom the eruptions disappeared while he was receiving cimetidine therapy prompted us to study ten additional patients with this disease.

Short-term cimetidine therapy (14 to 28 days) was started at a dosage of 1 g/day, with a reduction to 600 mg/day after two weeks. Eight of the patients suffering from both psoriasis and psoriatic arthritis were at the same time being treated with nonsteroidal anti-inflammatory drugs. In two psoriasis patients without arthritis, all oral as well as topical treatment was . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?